These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 38588960)

  • 1. Genomic characterization of circulating human respiratory syncytial viruses A and B in Kuwait using whole-genome sequencing.
    Madi N; Safar HA; Al-Adwani A; Sadeq M; Al-Turab M
    Microbiol Spectr; 2024 Jul; 12(7):e0015924. PubMed ID: 38808977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic characterization of human respiratory syncytial virus circulating in Islamabad, Pakistan, during an outbreak in 2022-2023.
    Haider SA; Jamal Z; Tahir F; Salman M; Umair M
    Arch Virol; 2024 Apr; 169(5):106. PubMed ID: 38644429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of COVID-19 Pandemic Restrictions on Respiratory Virus Patterns: Insights from RSV Surveillance in Gwangju, South Korea.
    Cho SJ; Kim SH; Mun J; Yun JE; Park S; Park J; Lee YU; Park JS; Yun H; Lee CM; Kim JP; Seo JM
    Viruses; 2024 May; 16(6):. PubMed ID: 38932143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Diversity of Human Respiratory Syncytial Virus during COVID-19 Pandemic in Yaoundé, Cameroon, 2020-2021.
    Moumbeket Yifomnjou MH; Monamele GC; Modiyinji AF; Njankouo-Ripa M; Onana B; Njouom R
    Microorganisms; 2024 May; 12(5):. PubMed ID: 38792782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A robust, scalable, and cost-efficient approach to whole genome sequencing of RSV directly from clinical samples.
    Köndgen S; Oh D-Y; Thürmer A; Sedaghatjoo S; Patrono LV; Calvignac-Spencer S; Biere B; Wolff T; Dürrwald R; Fuchs S; Reiche J
    J Clin Microbiol; 2024 Mar; 62(3):e0111123. PubMed ID: 38407068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of SARS-CoV-2 Pandemic and Lockdown on the HRSV Circulation: Experience of Three Spoke Hospitals in Northern Italy.
    Parola F; Brach Del Prever A; Deut V; Costagliola G; Guidi C; Ragusa N; Tuscano A; Timeus F; Berger M
    Viruses; 2024 Feb; 16(2):. PubMed ID: 38400006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RSV-GenoScan: An automated pipeline for whole-genome human respiratory syncytial virus (RSV) sequence analysis.
    Dosbaa A; Guilbaud R; Yusti AF; Ferré VM; Charpentier C; Descamps D; Le Hingrat Q; Coppée R
    J Virol Methods; 2024 Jun; 327():114938. PubMed ID: 38588779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological and phylogenetic assessment of human respiratory syncytial virus among pediatric patients presenting acute respiratory infections in Shiraz, Iran during 2015-2016.
    Mojarrad S; Tavakoli Movaghar N; Edalat F; Letafati A; Kargar Jahromi Z; Moattari A
    Iran J Microbiol; 2024 Jun; 16(3):411-420. PubMed ID: 39005603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolutionary trends of respiratory syncytial viruses: Insights from large-scale surveillance and molecular dynamics of G glycoprotein.
    Amjad MN; Wang J; Ashraf MA; Shen B; Din GU; Raza MA; Shoaib M; Yue L; Chen L; Xu H; Dong W; Hu Y
    Heliyon; 2024 May; 10(10):e30886. PubMed ID: 38784562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact in the adult population of immunization with nirsevimab in children under 6 months of age against respiratory syncytial virus].
    Reina J; Viana-Ramirez J
    Rev Esp Quimioter; 2024 Jul; ():. PubMed ID: 39010814
    [No Abstract]   [Full Text] [Related]  

  • 11. Whole-Genome Sequencing and Genetic Diversity of Human Respiratory Syncytial Virus in Patients with Influenza-like Illness in Sicily (Italy) from 2017 to 2023.
    Tramuto F; Maida CM; Randazzo G; Guzzetta V; Santino A; Li Muli R; Costantino C; Graziano G; Amodio E; Mazzucco W; Vitale F
    Viruses; 2024 May; 16(6):. PubMed ID: 38932144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservation of G-Protein Epitopes in Respiratory Syncytial Virus (Group A) Despite Broad Genetic Diversity: Is Antibody Selection Involved in Virus Evolution?
    Trento A; Ábrego L; Rodriguez-Fernandez R; González-Sánchez MI; González-Martínez F; Delfraro A; Pascale JM; Arbiza J; Melero JA
    J Virol; 2015 Aug; 89(15):7776-85. PubMed ID: 25995258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of human respiratory syncytial virus subtype B: a novel genotype of subtype B circulating in China.
    Ren L; Xiao Q; Zhou L; Xia Q; Liu E
    J Med Virol; 2015 Jan; 87(1):1-9. PubMed ID: 24910250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology and molecular characterization of respiratory syncytial viruses at a tertiary care university hospital in Catalonia (Spain) during the 2013-2014 season.
    Gimferrer L; Campins M; Codina MG; Martín Mdel C; Fuentes F; Esperalba J; Bruguera A; Vilca LM; Armadans L; Pumarola T; Antón A
    J Clin Virol; 2015 May; 66():27-32. PubMed ID: 25866332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic and genetic variation in human respiratory syncytial virus.
    Wertz GW; Moudy RM
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S19-24. PubMed ID: 14730266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic evolution of human respiratory syncytial virus during a decade (2013-2023): bridging the path to monoclonal antibody surveillance.
    Piñana M; González-Sánchez A; Andrés C; Vila J; Creus-Costa A; Prats-Méndez I; Arnedo-Muñoz M; Saubi N; Esperalba J; Rando A; Nadal-Baron P; Quer J; González-López JJ; Soler-Palacín P; Martínez-Urtaza J; Larrosa N; Pumarola T; Antón A
    J Infect; 2024 May; 88(5):106153. PubMed ID: 38588960
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.